Back
Assembly Biosciences Vs. Protagonist Therapeutics Industry Stock Comparison
Buy
53
ASMB
Assembly Biosciences
Last Price:
17.86
Seasonality Move:
2.99%
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
47.52
Seasonality Move:
13.55%
Buy
53
Assembly Biosciences (ASMB)
is a Buy
Is Assembly Biosciences a Buy, Sell or Hold?
- The current Assembly Biosciences [ASMB] share price is $18.50. The Score for ASMB is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ASMB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $47.64. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASMB Stock Price Chart
What is Assembly Biosciences's stock price today?
-
The Assembly Biosciences share price today is $18.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $47.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
ASMB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 64.81 | Buy |
| Chaikin Money Flow: | 19952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.96 - 18.04) | Buy |
| Bollinger Bands (100): | (13.87 - 16.61) | Buy |
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 65.65 | Buy |
| Chaikin Money Flow: | 126936 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.19 - 46.41) | Buy |
| Bollinger Bands (100): | (33.39 - 44.11) | Buy |
ASMB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.13 | Buy |
| 20-day SMA: | 16.13 | Buy |
| 50-day SMA: | 15.78 | Buy |
| 200-day SMA: | 13.83 | Buy |
| 8-day EMA: | 16.64 | Buy |
| 20-day EMA: | 16.23 | Buy |
| 50-day EMA: | 15.87 | Buy |
| 200-day EMA: | 14.35 | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.87 | Buy |
| 20-day SMA: | 45.2 | Buy |
| 50-day SMA: | 43.19 | Buy |
| 200-day SMA: | 33.03 | Buy |
| 8-day EMA: | 45.46 | Buy |
| 20-day EMA: | 44.91 | Buy |
| 50-day EMA: | 42.95 | Buy |
| 200-day EMA: | 34.35 | Buy |
Assembly Biosciences Earnings Growth & ASMB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.81 per share, and an increase next year of $0.78 per share.
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Assembly Biosciences Technical Analysis
| Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protagonist Therapeutics Technical Analysis
| Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||